These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 24186317

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activated prothrombin complex concentrate for dabigatran-associated bleeding.
    Schulman S, Ritchie B, Goy JK, Nahirniak S, Almutawa M, Ghanny S.
    Br J Haematol; 2014 Jan; 164(2):308-10. PubMed ID: 24383848
    [No Abstract] [Full Text] [Related]

  • 3. Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding.
    Wong H, Keeling D.
    Br J Haematol; 2014 Jul; 166(1):152-3. PubMed ID: 24617554
    [No Abstract] [Full Text] [Related]

  • 4. Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study.
    Sølbeck S, Nilsson CU, Engström M, Ostrowski SR, Johansson PI.
    Scand J Clin Lab Invest; 2014 Oct; 74(7):591-8. PubMed ID: 24909158
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reversal of dabigatran-induced bleeding by coagulation factor concentrates in a rat-tail bleeding model and lack of effect on assays of coagulation.
    van Ryn J, Schurer J, Kink-Eiband M, Clemens A.
    Anesthesiology; 2014 Jun; 120(6):1429-40. PubMed ID: 24714118
    [Abstract] [Full Text] [Related]

  • 8. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity.
    Dager WE, Gosselin RC, Roberts AJ.
    Crit Care Med; 2013 May; 41(5):e42-6. PubMed ID: 23474679
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS.
    Am J Health Syst Pharm; 2013 May 15; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [Abstract] [Full Text] [Related]

  • 16. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P, Working Group on Perioperative Haemostasis.
    Arch Cardiovasc Dis; 2013 May 15; 106(6-7):382-93. PubMed ID: 23810130
    [Abstract] [Full Text] [Related]

  • 17. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R, Salhanick SD, Chase M, Ganetsky M.
    Ann Emerg Med; 2013 Apr 15; 61(4):475-9. PubMed ID: 23522810
    [Abstract] [Full Text] [Related]

  • 18. Role of coagulation factor concentrates for reversing dabigatran-related anticoagulation.
    Levy JH.
    Anesthesiology; 2014 Jun 15; 120(6):1316-8. PubMed ID: 24722175
    [No Abstract] [Full Text] [Related]

  • 19. Reversal of a dabigatran overdose: what are possible options?
    Ratanapo S, Ungprasert P, Srivali N, Cheungpasitporn W, Bischof EF.
    Am J Med Sci; 2013 Sep 15; 346(3):259. PubMed ID: 23974270
    [No Abstract] [Full Text] [Related]

  • 20. Prothrombin complex concentrates in emergency bleeding disorders.
    Rodgers GM.
    Am J Hematol; 2012 Sep 15; 87(9):898-902. PubMed ID: 22648513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.